TickerFactsScreenerDevelopers

Aquestive Therapeutics, Inc. (AQST) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $9.21M2017: $17.38M2018: $60.60M2019: $49.33M2020: $31.81M$31.81M
2016Cash & Equivalents (USD)2020
Fiscal YearCash & EquivalentsChange YoY
2020$31.81M-35.5%
2019$49.33M-18.6%
2018$60.60M+248.7%
2017$17.38M+88.7%
2016$9.21M—